You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

myelofibrosis with myeloid metaplasia (MMM)

Showing 51 - 75 of 2,707
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial in Hangzhou (Jaktinib Hydrochloride Tablets)

Recruiting
  • Myelofibrosis
  • Jaktinib Hydrochloride Tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 28, 2022

Chronic Atrophic Gastritis Trial in Santa Rosa De Copan, San Juan (Curcumin, Laboratory Biomarker Analysis, Placebo

Active, not recruiting
  • Chronic Atrophic Gastritis
  • Santa Rosa De Copan, Honduras
  • +1 more
Dec 17, 2022

Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera

Completed
  • Adherence, Patient
  • Adherence, Treatment
    • Cosenza, Calabria, Italy
    • +27 more
    Oct 11, 2023

    Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

    Recruiting
    • Myelofibrosis
    • +3 more
    • Berkeley, California
    • +176 more
    Dec 1, 2022

    Myelofibrosis Trial in Paris (Ruxolotinib)

    Completed
    • Myelofibrosis
    • Paris, France
      ROBIN
    Jul 26, 2022

    Myelofibrosis Trial in Hong Kong (Bomedemstat)

    Recruiting
    • Myelofibrosis
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Oct 3, 2022

    Acute Myeloid Leukemia, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Farmington Hills, Sterling Heights

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Farmington Hills, Michigan
    • +1 more
    Jun 5, 2021

    Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    The Gastric HormonE BioMarkers of Preneoplastic Lesions Study

    Not yet recruiting
    • Stomach Neoplasm
    • +2 more
      • (no location specified)
      Oct 16, 2023

      Healthcare Resource Utilization in Adult Myelofibrosis Through

      Recruiting
      • Myelofibrosis
        • La Plata, Buenos Aires, Argentina
        • +62 more
        Feb 1, 2023

        Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

        Recruiting
        • Myelofibrosis
        • +3 more
        • Birmingham, Alabama
        • +13 more
        Jan 10, 2023

        Myelofibrosis Trial in Jinan (Ruxolitinib)

        Recruiting
        • Myelofibrosis
        • Jinan, Shandong, China
          Qilu Hospital of Shandong University
        Jul 3, 2022

        Real World Evidence of Fedratinib Effectiveness in MF

        Not yet recruiting
        • Primary Myelofibrosis
        • +2 more
        • (no location specified)
        May 22, 2023

        Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

        Active, not recruiting
        • Primary Myelofibrosis
        • Secondary Myelofibrosis
        • Laboratory Biomarker Analysis
        • +2 more
        • Scottsdale, Arizona
          Mayo Clinic in Arizona
        Jan 7, 2022

        Myelofibrosis Trial in Gilbert, Houston (APG-1252, Ruxolitinib)

        Withdrawn
        • Myelofibrosis
        • Gilbert, Arizona
        • +1 more
        Jul 8, 2022

        Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)

        Suspended
        • Myelofibrosis
        • Adelaide, South Australia, Australia
        • +37 more
        Aug 18, 2022

        Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in United States (Bosutinib, Dasatinib, Laboratory Biomarker

        Active, not recruiting
        • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • Anchorage, Alaska
        • +540 more
        Dec 14, 2022

        Digestive Inflammation Trial in Boulogne-Billancourt (Record during endoscopy of video-endoscopy sequences and reflectance)

        Recruiting
        • Digestive Inflammation
        • Record during endoscopy of video-endoscopy sequences and reflectance
        • Boulogne-Billancourt, Île-de-France, France
          Service Hépato-Gastroentérologie, Hôpital Ambroise Paré
        May 2, 2022

        Helicobacter Pylori Infection, Early Gastric Cancer, Endoscopic Resection Trial in Goyang (7 day H.pylori eradication Omeprazole

        Active, not recruiting
        • Helicobacter Pylori Infection
        • +2 more
        • 7 day H.pylori eradication Omeprazole or Rabeprazole, Clarithromycin, Amoxicillin
        • Placebo, Omeprazole or Rabeprazole, Clarithromycin
        • Goyang, Gyeonggi, Korea, Republic of
          National Cancer Center, Korea
        Apr 8, 2022

        Acute Myeloid Leukemia, Myeloproliferative Syndrome Trial in France (CPX-351)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Myeloproliferative Syndrome
        • Amiens, France
        • +33 more
        Feb 7, 2022

        Nilotinib for Chronic Myeloid Leukemia in First Line and Any

        Completed
        • Chronic Myeloid Leukemia
        • Nilotinib
        • Freudenstadt, Baden Wuerttemberg, Germany
        • +76 more
        Feb 9, 2023

        Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)

        Recruiting
        • Lymphoma, T-Cell, Peripheral
        • +4 more
        • MT-101
        • MT-101 + Conditioning (Lymphodepleting) Chemotherapy
        • Duarte, California
        • +8 more
        Jan 27, 2023

        Frequency and Risk Factors of Acute Myeloid Leukemia

        Not yet recruiting
        • Myeloid Leukemia
        • Bone marrow aspirite for diagnosis
        • (no location specified)
        Mar 15, 2023

        Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

        Recruiting
        • Myelofibrosis
        • +3 more
        • Birmingham, Alabama
        • +148 more
        Oct 10, 2022

        Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

        Recruiting
        • Myelofibrosis
        • La Jolla, California
        • +165 more
        Aug 19, 2022